Blue Owl Capital Inc - Ordinary Shares - Class A Forecast, price target & analysts
Blue Owl Capital Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation
Blue Owl Capital Inc - Ordinary Shares - Class A Classifications & Recommendation:
Blue Owl Capital Inc - Ordinary Shares - Class A Price Target
| Target Price | $23.46 |
| Price | $17.05 |
| Potential |
37.60%
register free of charge
|
| Number of Estimates | 16 |
|
16 Analysts have issued a price target Blue Owl Capital Inc - Ordinary Shares - Class A 2026 .
The average Blue Owl Capital Inc - Ordinary Shares - Class A target price is $23.46.
This is
37.60%
register free of charge
$30.45
78.59%
register free of charge
$21.21
24.40%
register free of charge
|
|
| A rating was issued by 20 analysts: 16 Analysts recommend Blue Owl Capital Inc - Ordinary Shares - Class A to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Blue Owl Capital Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of
37.60%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.30 | 2.69 |
| 32.56% | 17.28% | |
| EBITDA Margin | 40.93% | 57.21% |
| 12.23% | 39.78% | |
| Net Margin | 4.77% | 48.54% |
| 52.12% | 916.79% |
12 Analysts have issued a sales forecast Blue Owl Capital Inc - Ordinary Shares - Class A 2025 . The average Blue Owl Capital Inc - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Blue Owl Capital Inc - Ordinary Shares - Class A EBITDA forecast 2025. The average Blue Owl Capital Inc - Ordinary Shares - Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Blue Owl Capital Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Blue Owl Capital Inc - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.20 | 0.84 |
| 81.82% | 320.00% | |
| P/E | 20.22 | |
| EV/Sales | 10.97 |
15 Analysts have issued a Blue Owl Capital Inc - Ordinary Shares - Class A forecast for earnings per share. The average Blue Owl Capital Inc - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Blue Owl Capital Inc - Ordinary Shares - Class A...
Current Blue Owl Capital Inc - Ordinary Shares - Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Oppenheimer |
Locked
➜
Locked
|
Locked | Oct 14 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 13 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Oct 09 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 08 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Oct 06 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Oct 03 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Jul 28 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Oct 14 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 13 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Oct 09 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 08 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Oct 06 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Oct 03 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Jul 28 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
